SCHEMBL92240

SCHEMBL92240

CCC(C)OC(=O)c1ccc(C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
TDP1 Q9NUW8 1/20 0.52
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
TSHR P16473 1/20 0.46
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
MAPT P10636 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1965809 0.92 CA12 (0.53) L3MBTL1CA12CA1CA2CA7
SCHEMBL14690396 0.87 L3MBTL1 (0.56) L3MBTL1TDP1CA12CA1CA2
SCHEMBL569851 0.87 L3MBTL1 (0.56) L3MBTL1TDP1CA12CA1CA2
SCHEMBL4736415 0.87 CA12 (0.48) L3MBTL1CA12CA1CA2CA7
SCHEMBL6662441 0.86 TDP1 (0.46) L3MBTL1TDP1CA12CA1CA2
SCHEMBL17882060 0.86 L3MBTL1 (0.52) L3MBTL1TDP1CA12CA1CA2
SCHEMBL14722039 0.85 L3MBTL1 (0.55) L3MBTL1TDP1CA12CA1CA2
SCHEMBL10705086 0.85 CYP4F2 (0.53) L3MBTL1TDP1CA12CA1CA2
SCHEMBL9724886 0.85 CA12 (0.67) TDP1CA12CA1CA2CA7
SCHEMBL13784553 0.85 CA1 (0.52) L3MBTL1TDP1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014016129-A1 HOT MELT INK COMPOSITION, METHOD FOR PREPARING A HOT MELT INK COMPOSITION AND USE OF A HOT MELT INK COMPOSITION OCE-TECHNOLOGIES B.V. (NL) 2014-01-30 WO disclosed
US-8236728-B2 Heat-sensitive transfer sheet FUJIFILM CORPORATION (JP) 2012-08-07 US disclosed
US-8129310-B2 Heat-sensitive transfer sheet FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
US-7875325-B2 comprising a transparent film, and, on the film, at least one layer formed by applying a composition comprising a zirconium compound, a vinyl alcohol-based resin, and an aminocarboxylic acid or its derivative to a surface FUJIFILM CORPORATION (JP) 2011-01-25 US disclosed
US-7864205-B2 Heat-sensitive transfer image-forming method FUJIFILM CORPORATION (JP) 2011-01-04 US disclosed
EP-2264007-A1 NOVEL SALT HAVING FLUORINE-CONTAINING CARBANION STRUCTURE, DERIVATIVE THEREOF, PHOTOACID GENERATOR, RESIST MATERIAL USING THE PHOTOACID GENERATOR, AND PATTERN FORMING METHOD Central Glass Company, Limited (JP) 2010-12-22 EP disclosed
US-20090189968-A1 HEAT-SENSITIVE TRANSFER IMAGE-FORMING METHOD FUJIFILM CORPORATION (JP) 2009-07-30 US disclosed
US-20090086130-A1 OPTICAL FILM, POLARIZING PLATE, AND LIQUID-CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087598-A1 HEAT-SENSITIVE TRANSFER SHEET FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090060131-A1 HEAT-SENSITIVE TRANSFER SHEET FUJIFILM CORPORATION (JP) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090086130-A1 OPTICAL FILM, POLARIZING PLATE, AND LIQUID-CRYSTAL DISPLAY DEVICE ZKSCAN2, VCL, ZRANB2 L3MBTL1 564/4885TDP1 1605/4885CA12 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.